Skip to main content
Premium Trial:

Request an Annual Quote

Albert Einstein, Montefiore Land $25M CTSA Funding for Translational Center

NEW YORK (GenomeWeb News) – The Albert Einstein College of Medicine of Yeshiva University and Montefiore Medical Center have received $25 million in new funding from the National Institutes of Health to fund the Harold and Muriel Block Institute for Clinical and Translational Research (ICTR) at Einstein and Montefiore.

The ICTR, located in New York City, offers investigators a range of services to support their translational research activities. It received the funding under the National Center for Advancing Translational Sciences' Clinical and Translational Science awards program.

The center offers researchers access to labs to conduct an array of research projects, biorepositories for storing samples, and biomedical informatics resources, as well as research training and career development programs focused on translating research into clinical applications.

This round of funding marks the second CTSA award the ICTR has received. It landed its first grant in 2008.

"Over the past five years, the Block ICTR has succeeded in launching new multidisciplinary projects and networks, and provided critical tools for investigators in cancer, pediatrics, rare diseases, infectious diseases, liver disorders, aging, diabetes, and many others," Einstein Professor and Associate Dean for Clinical and Translational Research Harry Shamoon said in a statement.

At the center of the ICTR is the Project Acceleration Resource, which coordinates the ICTR and Einstein-Montefiore resources, and provides investigators access to resources and expertise in several areas. The PAR's resources include a Biomarker and Analytical Research Core; clinical trials and regulatory support; research informatics; a biorepository and sample processing; biostatistics and research study design; and patient safety and study implementation resources.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more